ISEC Healthcare forms joint venture to build ophthalmology centre in Johor

SGX Filings

2025/12/31

ISEC Healthcare said on Dec, 31 2025 that its wholly-owned subsidiary, ISEC Sdn. Bhd., has signed a joint-venture agreement with Bond Infinity, K.C. Yeo Eye Specialist Clinic and Wedjat Vision to incorporate ISEC (Batu Pahat) Sdn. Bhd. in Malaysia.

The new company will establish, operate and manage an ophthalmology centre in Batu Pahat, Johor. Initial issued capital will be 110 Malaysian ringgit shares, rising to RM1,064,890—about 0.34 million Singapore dollars—within nine months through new share subscriptions.

After the capital increase, ISEC Sdn. Bhd. will own 71.83% of the joint venture, which will be treated as an indirect subsidiary of ISEC Healthcare.

ISEC Healthcare will finance its contribution from internal resources. The firm said the transaction is classified as a non-discloseable event under Catalist Rule 1006 and will not materially affect its net tangible assets or earnings per share for the year ending Dec, 31 2025.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/1119313168"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1119313168\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1119313168?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-31 20:07","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1119313168","market":"sg","top_or_hot":-1,"title":"ISEC Healthcare forms joint venture to build ophthalmology centre in Johor","media":"SGX Filings","content":"<p>ISEC Healthcare said on Dec, 31 2025 that its wholly-owned subsidiary, ISEC Sdn. Bhd., has signed a joint-venture agreement with Bond Infinity, K.C. Yeo Eye Specialist Clinic and Wedjat Vision to incorporate ISEC (Batu Pahat) Sdn. Bhd. in Malaysia.</p>\n<p>The new company will establish, operate and manage an ophthalmology centre in Batu Pahat, Johor. Initial issued capital will be 110 Malaysian ringgit shares, rising to RM1,064,890—about 0.34 million Singapore dollars—within nine months through new share subscriptions.</p>\n<p>After the capital increase, ISEC Sdn. Bhd. will own 71.83% of the joint venture, which will be treated as an indirect subsidiary of ISEC Healthcare.</p>\n<p>ISEC Healthcare will finance its contribution from internal resources. The firm said the transaction is classified as a non-discloseable event under Catalist Rule 1006 and will not materially affect its net tangible assets or earnings per share for the year ending Dec, 31 2025.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ISEC Healthcare forms joint venture to build ophthalmology centre in Johor</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nISEC Healthcare forms joint venture to build ophthalmology centre in Johor\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1083912268\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/57d1beae95c40ebe9f2698a436562e39);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">SGX Filings </p>\n<p class=\"h-time\">2025-12-31 20:07</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>ISEC Healthcare said on Dec, 31 2025 that its wholly-owned subsidiary, ISEC Sdn. Bhd., has signed a joint-venture agreement with Bond Infinity, K.C. Yeo Eye Specialist Clinic and Wedjat Vision to incorporate ISEC (Batu Pahat) Sdn. Bhd. in Malaysia.</p>\n<p>The new company will establish, operate and manage an ophthalmology centre in Batu Pahat, Johor. Initial issued capital will be 110 Malaysian ringgit shares, rising to RM1,064,890—about 0.34 million Singapore dollars—within nine months through new share subscriptions.</p>\n<p>After the capital increase, ISEC Sdn. Bhd. will own 71.83% of the joint venture, which will be treated as an indirect subsidiary of ISEC Healthcare.</p>\n<p>ISEC Healthcare will finance its contribution from internal resources. The firm said the transaction is classified as a non-discloseable event under Catalist Rule 1006 and will not materially affect its net tangible assets or earnings per share for the year ending Dec, 31 2025.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"40T.SI","symbol_name":"国际眼科中心","start_time":0,"source_url":"","article_id":"1119313168","we_media_id":"1083912268","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1119313168","pubTimestamp":1767182879,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"SGX Filings","introduction":"Fastest News on SGX Filings ","home_visible":1,"id":"1083912268","head_image":"https://community-static.tradeup.com/news/57d1beae95c40ebe9f2698a436562e39"},"summary":"ISEC Healthcare said on Dec, 31 2025 that its wholly-owned subsidiary, ISEC Sdn. Bhd., has signed a joint-venture agreement with Bond Infinity, K.C. Yeo Eye Specialist Clinic and Wedjat Vision to...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"40T.SI":"国际眼科中心"},"translate_title":"ISEC Healthcare成立合资企业在柔佛州建设眼科中心","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"40T.SI":1},"content_text":"ISEC Healthcare said on Dec, 31 2025 that its wholly-owned subsidiary, ISEC Sdn. Bhd., has signed a joint-venture agreement with Bond Infinity, K.C. Yeo Eye Specialist Clinic and Wedjat Vision to incorporate ISEC (Batu Pahat) Sdn. Bhd. in Malaysia.\nThe new company will establish, operate and manage an ophthalmology centre in Batu Pahat, Johor. Initial issued capital will be 110 Malaysian ringgit shares, rising to RM1,064,890—about 0.34 million Singapore dollars—within nine months through new share subscriptions.\nAfter the capital increase, ISEC Sdn. Bhd. will own 71.83% of the joint venture, which will be treated as an indirect subsidiary of ISEC Healthcare.\nISEC Healthcare will finance its contribution from internal resources. The firm said the transaction is classified as a non-discloseable event under Catalist Rule 1006 and will not materially affect its net tangible assets or earnings per share for the year ending Dec, 31 2025.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"corporation,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}